Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Loiseau, P., Foret, T., DeFilippis, E. M., Risse, J., Etienne, A. D., Dufrost, V., Moulinet, T., Erkan, D., Devilliers, H., Wahl, D., & Zuily, S. (2022). Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus, 31(13), 1595–1605. https://doi.org/10.1177/09612033221126852
Authors:
Pierre Loiseau
Thomas Foret
Ersilia M DeFilippis
Jessie Risse
Anais D Etienne
Virginie Dufrost
Thomas Moulinet
Doruk Erkan
Hervé Devilliers
Denis Wahl
Stéphane Zuily
Affiliated Authors:
Ersilia M DeFilippis
Columbia Affiliation:
Author Keywords:
antiphospholipid antibodies
antiphospholipid syndrome
livedo
livedo racemosa
livedo reticularis
lupus anticoagulant
systemic lupus erythematosus
elink
Publication Type:
Article
Unique ID:
10.1177/09612033221126852
PMID:
36112747
DOI:
10.1177/09612033221126852
Journal:
Lupus
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: